• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

波兰人群中最常见的 BRCA1 突变的流行率。

Prevalence of the most frequent BRCA1 mutations in Polish population.

机构信息

Department of Biology and Genetics, Medical University of Gdansk, Debinki 1, Gdansk, Poland.

出版信息

J Appl Genet. 2011 Aug;52(3):325-30. doi: 10.1007/s13353-011-0040-6. Epub 2011 Apr 19.

DOI:10.1007/s13353-011-0040-6
PMID:21503673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3132391/
Abstract

The purpose of our study was to establish the frequency and distribution of the four most common BRCA1 mutations in Polish general population and in a series of breast cancer patients. Analysis of the population frequency of 5382insC (c.5266dupC), 300T >G (p.181T >G), 185delAG (c.68_69delAG) and 3819del5 (c.3700_3704del5) mutations of the BRCA1 gene were performed on a group of respectively 16,849, 13,462, 12,485 and 3923 anonymous samples collected at birth in seven Polish provinces. The patient group consisted of 1845 consecutive female breast cancer cases. The most frequent BRCA1 mutation in the general population was 5382insC found in 29 out of 16,849 samples (0.17%). 300T >G and 3819del5 mutations were found in respectively 11 of 13,462 (0.08%) and four of 3923 (0.1%) samples. The population prevalence for combined Polish founder 5382insC and 300T >G mutations was 0.25% (1/400). The frequencies of 5382insC and 300T >G carriers among consecutive breast cancer cases were, respectively, 1.9% (35/1845) and 1.2% (18/1486). Comparing these data with the population frequency, we calculated the relative risk of breast cancer for 5382insC mutation at OR = 17 and for 300T >G mutation at OR = 26. Our results, based on large population studies, show high frequencies of founder 5382insC and 300T >G BRCA1 mutations in Polish general population. Carriage of one of these mutations is connected with a very high relative risk of breast cancer.

摘要

我们研究的目的是确定波兰普通人群和一系列乳腺癌患者中四种最常见 BRCA1 突变的频率和分布。对 BRCA1 基因的 5382insC(c.5266dupC)、300T >G(p.181T >G)、185delAG(c.68_69delAG)和 3819del5(c.3700_3704del5)突变在出生时分别在波兰七个省采集的 16849、13462、12485 和 3923 个匿名样本组成的一组人群进行了分析。患者组由 1845 例连续女性乳腺癌病例组成。在普通人群中,最常见的 BRCA1 突变是 5382insC,在 16849 个样本中有 29 个(0.17%)发现。在 13462 个样本中有 11 个(0.08%)发现了 300T >G 突变,在 3923 个样本中有 4 个(0.1%)发现了 3819del5 突变。联合波兰创始人 5382insC 和 300T >G 突变的人群患病率为 0.25%(400 分之 1)。在连续乳腺癌病例中,5382insC 和 300T >G 携带者的频率分别为 1.9%(35/1845)和 1.2%(18/1486)。将这些数据与人群频率进行比较,我们计算出 5382insC 突变的乳腺癌相对风险为 17,300T >G 突变的乳腺癌相对风险为 26。我们基于大型人群研究的结果表明,波兰普通人群中存在高频率的创始人 5382insC 和 300T >G BRCA1 突变。携带其中一种突变与乳腺癌的极高相对风险相关。

相似文献

1
Prevalence of the most frequent BRCA1 mutations in Polish population.波兰人群中最常见的 BRCA1 突变的流行率。
J Appl Genet. 2011 Aug;52(3):325-30. doi: 10.1007/s13353-011-0040-6. Epub 2011 Apr 19.
2
Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases.波兰乳腺癌和卵巢癌病例中家族史对 BRCA1 基因突变存在的意义有限。
Fam Cancer. 2012 Sep;11(3):351-4. doi: 10.1007/s10689-012-9519-5.
3
BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study.波兰人群中的 BRCA1 种系突变及其他:BRCA1/2 下一代测序的单机构研究。
PLoS One. 2018 Jul 24;13(7):e0201086. doi: 10.1371/journal.pone.0201086. eCollection 2018.
4
Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.匈牙利乳腺癌和卵巢癌患者中始祖BRCA1和BRCA2突变的患病率。
Int J Cancer. 2000 Jun 1;86(5):737-40. doi: 10.1002/(sici)1097-0215(20000601)86:5<737::aid-ijc21>3.0.co;2-1.
5
Prevalence of two BRCA1 mutations, 5382insC and 300T > G, in ovarian cancer patients from Ukraine.乌克兰卵巢癌患者中两种BRCA1突变(5382insC和300T > G)的患病率。
Fam Cancer. 2017 Oct;16(4):471-476. doi: 10.1007/s10689-017-9978-9.
6
BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland.波兰东北部乳腺癌-卵巢癌家族中BRCA1和BRCA2基因突变分析
Hum Mutat. 2003 May;21(5):553-4. doi: 10.1002/humu.9139.
7
Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.与波兰人群乳腺癌风险增加相关的BRCA1和BRCA2基因结构改变的分子诊断的选定方面
Hered Cancer Clin Pract. 2006 Aug 15;4(3):142-52. doi: 10.1186/1897-4287-4-3-142.
8
Recurrent mutations of BRCA1 and BRCA2 in Poland: an update.波兰BRCA1和BRCA2基因的复发性突变:最新情况
Clin Genet. 2015 Mar;87(3):288-92. doi: 10.1111/cge.12360. Epub 2014 Mar 12.
9
High frequency of BRCA1 founder mutations in Polish women with nonfamilial breast cancer.波兰非家族性乳腺癌女性中 BRCA1 种系突变的高频发生。
Fam Cancer. 2012 Dec;11(4):623-8. doi: 10.1007/s10689-012-9560-4.
10
Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.波兰东北部乳腺癌和/或卵巢癌家族中的始祖BRCA1突变及两种新的种系BRCA2突变
Hum Mutat. 2000 May;15(5):480-1. doi: 10.1002/(SICI)1098-1004(200005)15:5<480::AID-HUMU13>3.0.CO;2-G.

引用本文的文献

1
and Mutations in Polish Women with Ductal Carcinoma In Situ.波兰导管原位癌女性的基因突变情况
Cancers (Basel). 2025 Feb 11;17(4):613. doi: 10.3390/cancers17040613.
2
Next-generation sequencing methodologies to detect low-frequency mutations: "Catch me if you can".下一代测序方法检测低频突变:“若能抓住,尽管来抓”。
Mutat Res Rev Mutat Res. 2023 Jul-Dec;792:108471. doi: 10.1016/j.mrrev.2023.108471. Epub 2023 Sep 15.
3
The cancer-risk variant frequency among Polish population reported by the first national whole-genome sequencing study.

本文引用的文献

1
The contribution of founder mutations in BRCA1 to breast and ovarian cancer in Lithuania.BRCA1 种系突变在立陶宛乳腺癌和卵巢癌发病中的作用。
Clin Genet. 2010 Oct;78(4):373-6. doi: 10.1111/j.1399-0004.2010.01404.x.
2
Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women.在未选择的犹太女性中筛查 BRCA1 和 BRCA2 的种系突变。
J Clin Oncol. 2010 Jan 20;28(3):387-91. doi: 10.1200/JCO.2009.25.0712. Epub 2009 Dec 14.
3
Loss of heterozygosity at BRCA1/2 loci in hereditary and sporadic ovarian cancers.BRCA1/2 基因座杂合性缺失在遗传性和散发性卵巢癌中的研究。
第一项全国全基因组测序研究报告的波兰人群中癌症风险变异的频率。
Front Oncol. 2023 Feb 10;13:1045817. doi: 10.3389/fonc.2023.1045817. eCollection 2023.
4
The highest frequency of c.3700_3704del detected among Albanians from Kosovo.在来自科索沃的阿尔巴尼亚人中检测到的c.3700_3704del的最高频率。
Rep Pract Oncol Radiother. 2022 May 19;27(2):303-309. doi: 10.5603/RPOR.a2022.0030. eCollection 2022.
5
Genetic diversity in Kashubs: the regional increase in the frequency of several disease-causing variants.卡舒布人的遗传多样性:几种致病变体频率的区域性增加。
J Appl Genet. 2022 Dec;63(4):691-701. doi: 10.1007/s13353-022-00713-z. Epub 2022 Aug 15.
6
Heterogeneity of germline variants in high risk breast and ovarian cancer susceptibility genes in India.印度高危乳腺癌和卵巢癌易感基因种系变异的异质性
Precis Clin Med. 2018 Sep;1(2):75-87. doi: 10.1093/pcmedi/pby010. Epub 2018 Sep 22.
7
Genetic testing in Poland and Ukraine: should comprehensive germline testing of and be recommended for women with breast and ovarian cancer?波兰和乌克兰的基因检测:是否应推荐对乳腺癌和卵巢癌女性进行全面胚系检测?
Genet Res (Camb). 2020 Aug 10;102:e6. doi: 10.1017/S0016672320000075.
8
Spectrum and Prevalence of Pathogenic Variants in Ovarian Cancer Susceptibility Genes in a Group of 333 Patients.333例患者卵巢癌易感基因致病变异的谱型及患病率
Cancers (Basel). 2018 Nov 14;10(11):442. doi: 10.3390/cancers10110442.
9
Genetics of breast cancer in African populations: a literature review.非洲人群乳腺癌的遗传学:文献综述
Glob Health Epidemiol Genom. 2018 May 11;3:e8. doi: 10.1017/gheg.2018.8. eCollection 2018.
10
Establishment and Characterization of the Novel High-Grade Serous Ovarian Cancer Cell Line OVPA8.新型高级别浆液性卵巢癌细胞系 OVPA8 的建立与鉴定。
Int J Mol Sci. 2018 Jul 17;19(7):2080. doi: 10.3390/ijms19072080.
J Appl Genet. 2009;50(4):379-84. doi: 10.1007/BF03195697.
4
BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications.BRCA1 和 BRCA2 基因突变与种族和民族:分布及临床意义。
Curr Opin Obstet Gynecol. 2010 Feb;22(1):72-8. doi: 10.1097/GCO.0b013e328332dca3.
5
BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.不同种族接受遗传性乳腺癌-卵巢癌检测的女性中的BRCA1和BRCA2突变
Cancer. 2009 May 15;115(10):2222-33. doi: 10.1002/cncr.24200.
6
BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research.乳腺癌家族登记处中的BRCA1和BRCA2突变携带者:一个用于合作研究的开放资源。
Breast Cancer Res Treat. 2009 Jul;116(2):379-86. doi: 10.1007/s10549-008-0153-8. Epub 2008 Aug 14.
7
Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer.高危捷克乳腺癌和/或卵巢癌患者中BRCA1和BRCA2有害突变的谱系及特征分析
BMC Cancer. 2008 May 20;8:140. doi: 10.1186/1471-2407-8-140.
8
Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.美国5个种族/族裔群体中致病性BRCA1突变携带者的患病率。
JAMA. 2007 Dec 26;298(24):2869-76. doi: 10.1001/jama.298.24.2869.
9
BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.波兰北部乳腺癌和卵巢癌家族中BRCA1和BRCA2基因的点突变及大片段重排
Oncol Rep. 2008 Jan;19(1):263-8.
10
High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland.波兰连续卵巢癌患者中BRCA1/2种系突变的高频率
Gynecol Oncol. 2008 Feb;108(2):433-7. doi: 10.1016/j.ygyno.2007.09.035. Epub 2007 Nov 7.